Evidence map›Paper›PMID 39293488›Full record

ArticleNature medicine2024

Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon region.

Felipe Gomes Naveca, Tatiana Amaral Pires de Almeida, Victor Souza, Valdinete Nascimento, Dejanane Silva, Fernanda Nascimento, Matilde Mejía, Yasmin Silva de Oliveira, Luisa Rocha, Natana Xavier and 50 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Emergence of Oropouche Virus, Venezuela, 2025.Emerging infectious diseases · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Five Hot Topics in Tropical Medicine: 2025.Infectious disease reports · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors.

Felipe Gomes NavecaNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil. felipe.naveca@fiocruz.br.ORCID http://orcid.org/0000-0002-2888-1060
Tatiana Amaral Pires de AlmeidaNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.ORCID http://orcid.org/0009-0007-9086-8530
Victor SouzaNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.
Valdinete NascimentoNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.
Dejanane SilvaNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.
Fernanda NascimentoNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.
Matilde MejíaNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.
Yasmin Silva de OliveiraNúcleo de Vigilância de Vírus Emergentes, Reemergentes ou Negligenciados - ViVER/EDTA, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.
Luisa RochaLaboratório Central de Saúde Pública de Roraima, Boa Vista, Brazil.
Natana XavierLaboratório Central de Saúde Pública de Roraima, Boa Vista, Brazil.
Janis LopesLaboratório Central de Saúde Pública de Roraima, Boa Vista, Brazil.
Rodrigo MaitoLaboratório Central de Saúde Pública de Roraima, Boa Vista, Brazil.
Cátia MenesesLaboratório Central de Saúde Pública de Roraima, Boa Vista, Brazil.
Tatyana AmorimFundação de Vigilância em Saúde - Dra. Rosemary Costa Pinto, Manaus, Brazil.
Luciana FéFundação de Vigilância em Saúde - Dra. Rosemary Costa Pinto, Manaus, Brazil.
Fernanda Sindeaux CameloFundação de Vigilância em Saúde - Dra. Rosemary Costa Pinto, Manaus, Brazil.ORCID http://orcid.org/0000-0002-1680-2310
Samyly Coutinho de Aguiar SilvaFundação de Vigilância em Saúde - Dra. Rosemary Costa Pinto, Manaus, Brazil.
Alexsandro Xavier de MeloFundação de Vigilância em Saúde - Dra. Rosemary Costa Pinto, Manaus, Brazil.
Leíse Gomes FernandesFundação de Vigilância em Saúde - Dra. Rosemary Costa Pinto, Manaus, Brazil.
Marco Aurélio Almeida de OliveiraLaboratório Central de Saúde Pública do Amazonas, Manaus, Brazil.
Ana Ruth ArcanjoLaboratório Central de Saúde Pública do Amazonas, Manaus, Brazil.
Guilherme AraújoLaboratório Central de Saúde Pública do Amazonas, Manaus, Brazil.
Walter André JúniorLaboratório Central de Saúde Pública do Amazonas, Manaus, Brazil.
Renata Lia Coragem de CarvalhoLaboratório Central de Saúde Pública do Amazonas, Manaus, Brazil.
Rosiane RodriguesLaboratório Central de Saúde Pública de Rondônia, Porto Velho, Brazil.
Stella AlbuquerqueLaboratório Central de Saúde Pública de Rondônia, Porto Velho, Brazil.
Cristiane MattosLaboratório Central de Saúde Pública de Rondônia, Porto Velho, Brazil.
Ciciléia SilvaLaboratório Central de Saúde Pública de Rondônia, Porto Velho, Brazil.
Aline LinharesLaboratório Central de Saúde Pública de Rondônia, Porto Velho, Brazil.
Taynã RodriguesLaboratório Central de Saúde Pública do Acre, Rio Branco, Brazil.
Francy MariscalLaboratório Central de Saúde Pública do Acre, Rio Branco, Brazil.
Márcia Andréa MoraisNúcleo de Doenças de Transmissão Vetorial, Secretaria Estadual de Saúde do Acre, Rio Branco, Brazil.
Mayra Marinho PresibellaLaboratório Central de Saúde Pública do Paraná, Curitiba, Brazil.
Nelson Fernando Quallio MarquesLaboratório Central de Saúde Pública do Paraná, Curitiba, Brazil.
Anne PaivaCoordenação Geral de Laboratórios de Saúde Pública - CGLAB, Ministério da Saúde, Brasília, Brazil.
Karina RibeiroCoordenação Geral de Laboratórios de Saúde Pública - CGLAB, Ministério da Saúde, Brasília, Brazil.
Deusilene VieiraLaboratório de Virologia Molecular, Fiocruz Rondônia, Porto Velho, Brazil.
Jackson Alves da Silva QueirozLaboratório de Virologia Molecular, Fiocruz Rondônia, Porto Velho, Brazil.
Ana Maísa Passos-SilvaLaboratório de Virologia Molecular, Fiocruz Rondônia, Porto Velho, Brazil.
Lígia AbdallaUniversidade do Estado do Amazonas, Manaus, Brazil.
João Hugo SantosUniversidade Federal do Amazonas, Manaus, Brazil.
Regina Maria Pinto de FigueiredoGerência de Virologia, Fundação de Medicina Tropical - Dr. Heitor Vieira Dourado, Manaus, Brazil.
Ana Cecília Ribeiro CruzDepartment of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua, Brazil.
Livia Neves CassebDepartment of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua, Brazil.
Jannifer Oliveira ChiangDepartment of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Ministry of Health, Ananindeua, Brazil.
Livia Vinhal FrutuosoCoordenação-Geral de Vigilância de Arboviroses - CGARB, Departamento de Doenças Transmissíveis, Secretaria de Vigilância em Saúde e Ambiente, Ministério da Saúde, Brasília, Brazil.
Agata RossiLaboratório de Genômica e Ecologia Viral, Departamento de Patologia, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, Brazil.
Lucas FreitasGISAID Global Data Science Initiative, Munich, Germany.ORCID http://orcid.org/0000-0002-8766-0890
Túlio de Lima CamposInstituto Aggeu Magalhães, Fiocruz, Recife, Brazil.
Gabriel Luz WallauInstituto Aggeu Magalhães, Fiocruz, Recife, Brazil.ORCID http://orcid.org/0000-0002-1419-5713
Emerson MoreiraUniversidade Federal de Pernambuco, Recife, Brazil.
Roberto Dias Lins NetoInstituto Aggeu Magalhães, Fiocruz, Recife, Brazil.ORCID http://orcid.org/0000-0002-3983-8025
Laura W AlexanderDepartment of Integrative Biology, University of California, Berkeley, Berkeley, CA, USA.
Yining SunDepartment of Public and Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Ana Maria Bispo de FilippisLaboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Tiago GräfLaboratório de Virologia Molecular, Instituto Carlos Chagas, Fiocruz, Curitiba, Brazil.ORCID http://orcid.org/0000-0003-4921-7975
Ighor ArantesLaboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Ana I BentoDepartment of Public and Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.ORCID http://orcid.org/0000-0001-7728-007X
Edson DelatorreLaboratório de Genômica e Ecologia Viral, Departamento de Patologia, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, Brazil.
Gonzalo BelloLaboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil. gbellobr@gmail.com.ORCID http://orcid.org/0000-0002-2724-2793

Funding

Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 421620/2023-4
6 · The paper itself

Abstract

The Brazilian western Amazon is experiencing its largest laboratory-confirmed Oropouche virus (OROV) outbreak, with more than 6,300 reported cases between 2022 and 2024. In this study, we sequenced and analyzed 382 OROV genomes from human samples collected in Amazonas, Acre, Rondônia and Roraima states, between August 2022 and February 2024, to uncover the origin and genetic evolution of OROV in the current outbreak. Genomic analyses revealed that the upsurge of OROV cases in the Brazilian Amazon coincides with spread of a novel reassortant lineage containing the M segment of viruses detected in the eastern Amazon region (2009-2018) and the L and S segments of viruses detected in Peru, Colombia and Ecuador (2008-2021). The novel reassortant likely emerged in the Amazonas state between 2010 and 2014 and spread through long-range dispersion events during the second half of the 2010s. Phylodynamics reconstructions showed that the current OROV spread was driven mainly by short-range (< 2 km) movements consistent with the flight range of vectors. Nevertheless, a substantial proportion (22%) of long-range (>10 km) OROV migrations were also detected, consistent with viral dispersion by humans. Our data provide a view of the unprecedented spread and evolution of OROV in the Brazilian western Amazon region.

Indexed as

Bunyaviridae InfectionsDisease OutbreaksGenome, ViralOrthobunyavirusPhylogenyReassortant VirusesAnimalsBrazilHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.